Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00484_DB01247_nanopub.RAAC3j8iYx2CoYHwMj8GLMtWppLohGO07rEbzB-4w1t8s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00484_DB01247 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00484_DB01247 label "DDI between Brimonidine and Isocarboxazid - MAO Inhibitors like isocarboxazid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB01247]" assertion.
- drugbank_resource:DB00484_DB01247 identifier "drugbank_resource:DB00484_DB01247" assertion.
- drugbank_resource:DB00484_DB01247 title "DDI between Brimonidine and Isocarboxazid - MAO Inhibitors like isocarboxazid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated." assertion.
- drugbank:DB00484 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB01247 assertion.
- drugbank:DB01247 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB01247 assertion.